Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1971-6-2
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0022-9032
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7-17
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:5552714-Acute Disease,
pubmed-meshheading:5552714-Administration, Oral,
pubmed-meshheading:5552714-Arrhythmias, Cardiac,
pubmed-meshheading:5552714-Female,
pubmed-meshheading:5552714-Follow-Up Studies,
pubmed-meshheading:5552714-Humans,
pubmed-meshheading:5552714-Male,
pubmed-meshheading:5552714-Propranolol,
pubmed-meshheading:5552714-Time Factors
|
pubmed:year |
1971
|
pubmed:articleTitle |
[Value of Inderal in long-term treatment of cardiac arrhythmias].
|
pubmed:publicationType |
Journal Article
|